Yadarisa Shabong
News
AstraZeneca antibody cocktail study shows success treating COVID-19
October 12, 2021
The drug reduced the risk of severe COVID-19 or death by 50% in non-hospitalized patients who have had symptoms for seven days or less.
The drug reduced the risk of severe COVID-19 or death by 50% in non-hospitalized patients who have had symptoms for seven days or less.